期刊文献+

护卵汤治疗心肾不交型卵巢早衰的临床观察 被引量:28

Clinical study of Huluan decoction on premature ovarian failure of heart-kidney imbalance
下载PDF
导出
摘要 目的对护卵汤治疗心肾不交型卵巢早衰的临床疗效进行评价。方法采用随机、阳性药物对照方法,收集病例治疗组30例,对照组30例。治疗组予以护卵汤治疗,对照组采用妈富隆人工周期替代疗法(HRT)治疗,观测2组治疗前后疗效比较、症状评分、血清激素水平(FSH、LH、E2)变化。结果 2组患者治疗前后症状评分、血清激素水平均有显著性变化(P<0.05),中医证侯积分比较治疗组优于对照组(P<0.05),总有效率分别为86.67%和70.00%,两组比较差异有统计学意义(P<0.05)。结论护卵汤对肾虚精亏心肾不交型卵巢早衰患者的血清激素水平和主要症状均有显著改善作用,在改善患者症状方面比对照组更具优势,且治愈率更高,疗效更稳定。 Objective To evaluate the clinical efficacy of Huluan decoction for premature ovarian failure of heart-kidney imbalance.Method Sixty patients were randomly divided into treatment group treated with Huluan decoction and control group treated with HRT;and the changes of two group's symptom score and serum hormone levels were measured.Result The symptom score,serum hormone levels of the patients in two groups before and after treatment were significant changes(P0.05),the integrals of TCM syndrome in treatment group was better than that in control group(P0.05),and the total effective rate in treatment group was 86.67% and in control group 70.00%(P0.05).Conclusion Huluan decoction is effective to improve the level of sserum hormones and main symptoms for premature ovarian failure of heart-kidney imbalance,and it has more superiority and higher curative effect in improving symptoms.
机构地区 湖南中医药大学
出处 《湖南中医药大学学报》 CAS 2010年第9期184-186,共3页 Journal of Hunan University of Chinese Medicine
基金 湖南省自然科学基金资助项目(05JJ30149)
关键词 卵巢早衰 护卵汤 妈富隆人工周期替代疗法 心肾不交 临床观察 紫石英 菟丝子 补骨脂 POF(premature ovarian failure) Huluan decoction Marvelon artificial cycle replacement therapy heart-kidney imbalance clinical study amethyst
  • 相关文献

参考文献6

二级参考文献12

  • 1彭丽芳,王莉莉,唐晖.妈富隆治疗青春期功血72例临床分析[J].中国实用医药,2007,2(10):82-83. 被引量:5
  • 2Laml T, Schulz- Lobmeyr I, Obruca A, et al. Premature ovarian failure:etiology and prospects. Gynecol Endocrinol,2000 Aug, 14:292-302.
  • 3Kim TJ, Anasti JN, Flack MR, et al. Routine endocrine acreening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol, 1997,89:777-779.
  • 4Kalantaridou SN, Davis SR, Nelson LM. Premature ovarian failure. Endocrinology and Metabolism Clinics of North America, 1998,27:989-1006.
  • 5Nelson LM, Anasti .IN, Kimaey LM, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab, 1994,79:1470-1475.
  • 6Anasti JN, Kalantaridou SN, Kimzey LM, et al. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol, 1998,91 : 12-15.
  • 7Novosad JA, Kalantaridou SN, Tong ZB, et al. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health,2003,3: 2.
  • 8曹泽毅.中华妇产科学(下册)[M].北京:人民卫生出版社,2004.2091.
  • 9卢红.妈富隆治疗青春期功能失调性子宫出血28例临床分析[J].现代医药卫生,2007,23(23):3508-3509. 被引量:2
  • 10苏里,王世红.妈富隆治疗青春期功血96例临床研究[J].中国医药导报,2008,5(29):53-53. 被引量:5

共引文献574

同被引文献419

引证文献28

二级引证文献259

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部